MedPath

To study the effect of Ashwagnadha by polysomnogram on non-restorative sleep

Phase 3
Registration Number
CTRI/2021/11/038157
Lead Sponsor
International Institute of Seep Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The following criteria are to be checked at the time of screening. The subject may only be included in the study if ALL the following statements are FULLFILLED:

1.With age of at least 18 years to 65 years

2.RSQ-W total score ï?£ 50

3.Have not taken any hypnotic medicines, Supplements or Ashwagandha within last 3 months

4.Able to communicate and read in English

5.Women of child-bearing potential (refer to appendix for definition) willing to use an adequate method of contraception to avoid pregnancy throughout the study period

6.Covid vaccinated for at least 4 weeks

7.No Caffeine or Alcohol intake 12 hours prior to Polysomnogram study

8.Willing to provide written informed consent

Exclusion Criteria

Those having heart disease, severe sleep apnea, severe plmd, severe anxiety and depression, pregnant women.History of alcohol and drug abuse. participants who were in other clinical trial for last 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean percent change in CAP rate Between Baseline and End of Treatment duration of 8 weeks. Comparison will be made between treatment arms.Timepoint: Visit 4, Visit 5 and Visit 6
Secondary Outcome Measures
NameTimeMethod
1.Comparison of Change in NRS scores <br/ ><br>2.Adverse effects <br/ ><br>3. Changes in other Sleep parameters such as Total Sleep time, Sleep Efficiency, Microarousal index, REM latency. <br/ ><br>4.Changes in PSQI scores <br/ ><br>5.Change in HADS scores <br/ ><br>Timepoint: Visit 4, Visit 5 and Visit 6
© Copyright 2025. All Rights Reserved by MedPath